Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 26;10(1):126.
doi: 10.1186/s13756-021-00995-8.

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition

Cong Yao #  1 , Haiping Guo #  1 , Qiang Li #  2 , Xuxia Zhang  1 , Yuanyuan Shang  1 , Tongxin Li  3 , Yufeng Wang  4 , Zhongtan Xue  4 , Lu Wang  1 , Liang Li  1 , Yu Pang  5
Affiliations

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition

Cong Yao et al. Antimicrob Resist Infect Control. .

Abstract

Objectives: Recently, the definition of extensively drug-resistant TB (XDR-TB) has been revised. In this study, we conducted a descriptive and retrospective study to determine the prevalence of XDR-TB in a Chinese multidrug-resistant TB (MDR-TB) cohort.

Methods: Broth microdilution method was performed to determine in vitro susceptibilities of Mycobacterium tuberculosis (MTB) isolates to (FQs), bedaquiline (BDQ) and linezolid (LZD). The putative drug target genes conferring drug resistance were screened by DNA sequencing.

Results: A total of 425 MDR-TB isolates were included from 13 pilots in China. LZD and BDQ resistance were noted in 30 (7.1%) and 10 (2.4%) isolates. On the basis of latest definitions, 114 (26.8%) were MDR-TB, 282 (66.4%) were pre-XDR-TB, and 29 (6.8%) were XDR-TB. Among 311 FQ-resistant isolates, 265 harbored genetic mutations within QRDRs. The most common mutations were observed at codon 94 of gyrA, accounting for 47.2% of FQ-resistant MTB isolates. Only mutations within the Rv0678 gene were found to confer BDQ resistance in our cohort, conferring 40.0% of BDQ resistance. For LZD resistance, 53.3% of LZD-resistant isolates carried genetic mutations in rplC or 23S rRNA. The most frequent mutation was Cys154Arg in the rplC gene. In addition, we recorded two MDR-TB patients with resistance to both BDQ and LZD, of which one patient experienced continuous positive culture of MTB despite inclusion of efficacious moxifloxacin.

Conclusion: Our results demonstrate that the low prevalence of XDR-TB holds great promise for MDR-TB treatment with WHO-endorsed regimens containing BDQ-LZD combination, whereas the high prevalence of FQ-resistance in MDR-TB patients warrants national attention.

Keywords: Mycobacterium tuberculosis; Susceptibility; XDR.

PubMed Disclaimer

Conflict of interest statement

All authors: no conflicts.

Figures

Fig. 1
Fig. 1
Distribution of MDR-TB isolates stratified to in vitro susceptibility testing. MDR, multidrug resistance; pre-XDR, pre-extensive drug-resistance; XDR, extensive drug-resistance; FQ, fluroquinolone; LZD, linezolid; BDQ, bedaquiline
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization . Global tuberculosis report 2020. Geneva: WHO; 2020.
    1. Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, et al. Tuberculosis elimination: where are we now? Eur Respir Rev. 2018;27(148):180035. doi: 10.1183/16000617.0035-2018. - DOI - PMC - PubMed
    1. Furin J, Brigden G, Lessem E, Rich M, Vaughan L, Lynch S. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerg Infect Dis. 2016;22(3):e151430. doi: 10.3201/eid2203.151430. - DOI - PMC - PubMed
    1. Xu C, Pang Y, Li R, Ruan Y, Wang L, Chen M, et al. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. J Infect. 2018;76(4):348–353. doi: 10.1016/j.jinf.2017.12.017. - DOI - PubMed
    1. Daley CL, Caminero JA. Management of multidrug-resistant tuberculosis. Semin Respir Crit Care Med. 2018;39(3):310–324. doi: 10.1055/s-0038-1661383. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources